We examined a panel of primary AML blood samples of 33 patients with varied morphological and karyotypic classifications (S1 Table) for cell surface protein expression of CD302 by flow cytometry (Fig 1A) using MMRI-20. The gene discussed is CD302; the disease is acute myeloid leukemia.